| 1404 |
National Cancer Institute |
Html |
en |
Sleep Disorders (PDQ®)–Patient Version |
Expert-reviewed information summary about causes and management of sleep disorders in people with cancer. |
| normal sleep patterns | 0.734479 |
| Relaxation therapy | 0.493159 |
| moderate sleep disorders | 0.656166 |
| sleeping problems | 0.484122 |
| PDQ cancer information | 0.646663 |
| sleep medicines | 0.601935 |
| health care team | 0.479673 |
| clinical trials | 0.518721 |
| sleep history | 0.612308 |
| sleep apnea | 0.593611 |
| cancer patient sleeps | 0.499804 |
| cancer information summary | 0.579061 |
| clinical trial | 0.483994 |
| breast cancer prevention | 0.483786 |
| good sleep habits | 0.703452 |
| cancer patients | 0.541537 |
| treatment instructions | 0.483188 |
| sleep problems | 0.627478 |
| mild sleep disorders | 0.656367 |
| NCI’s PDQ | 0.480637 |
| NCI PDQ cancer | 0.525102 |
| Common cancer treatments | 0.495476 |
| sleep disorder clinic | 0.627008 |
| deep sleep | 0.635758 |
|
| treatment | 0.54776 |
| cancer prevention | 0.48441 |
| lighter sleep | 0.598128 |
| Cancer Information Service | 0.493437 |
| REM sleep | 0.662129 |
| sleep | 0.949433 |
| good night | 0.507447 |
| National Cancer Institute | 0.585654 |
| sleep repeat | 0.634943 |
| light sleep | 0.635787 |
| Palliative Care Editorial | 0.524141 |
| new treatment | 0.481731 |
| sleep disorders | 0.849206 |
| sleep restriction | 0.605553 |
| Cancer Care page | 0.486706 |
| Care Editorial Board | 0.525467 |
| health | 0.498616 |
| PDQ summary | 0.533115 |
| sleep disorder | 0.712776 |
| sleep problem | 0.601447 |
| cancer information summaries | 0.498019 |
| comprehensive cancer information | 0.497854 |
| cancer | 0.67715 |
| stimulus control | 0.540953 |
|
CLICK HERE |
| 1908 |
National Cancer Institute |
Html |
es |
Tratamiento de la leucemia mieloide aguda en adultos (PDQ®)–Versión para pacientes |
Resumen de información revisada por expertos acerca del tratamiento de la leucemia mieloide aguda en adultos. |
| linfocÃtica aguda | 0.505572 |
| leucemia promielocÃtica aguda | 0.536157 |
| siguientes procedimientos | 0.505247 |
| células madre | 0.703397 |
| leucemia mielógena aguda | 0.512482 |
| posibles factores | 0.501447 |
| siguientes aspectos | 0.5019 |
| leucemia aguda | 0.511873 |
| radiación quizás | 0.505162 |
| leucemia linfoblástica aguda | 0.535526 |
| LMA quizás | 0.505703 |
| hueso compacto | 0.505434 |
| neoplasias mieloides | 0.501631 |
| rayos x | 0.501258 |
| enlace drugs approved | 0.505977 |
| Acute Myeloid Leukemia | 0.506164 |
| célula madre mieloide | 0.516071 |
| cáncer.ampliar aspiración | 0.501565 |
| lÃquido cefalorraquÃdeo | 0.511938 |
|
| punción espinal.Ampliar | 0.501523 |
| National Cancer Institute | 0.501258 |
| leucemia granulocÃtica aguda | 0.512402 |
| Instituto Nacional | 0.502137 |
| célula madre linfoide | 0.510737 |
| PDQ Tratamiento | 0.503456 |
| sustancia quÃmica benceno | 0.502803 |
| leucemia mielógena | 0.513696 |
| médula espinal.ampliar quimioterapia | 0.50588 |
| leucemia mieloblástica aguda | 0.512403 |
| sistema nervioso central | 0.50789 |
| Physician Data Query | 0.504454 |
| madre mieloides | 0.518606 |
| siguientes situaciones | 0.504197 |
| células madre mieloides | 0.508803 |
| leucemia mieloide aguda | 0.995372 |
| célula madre | 0.532153 |
| blastocito mieloide | 0.505386 |
| siguientes sumarios | 0.503116 |
|
CLICK HERE |
| 1927 |
National Cancer Institute |
Html |
es |
Tratamiento del linfoma de Hodgkin infantil (PDQ®)–Versión para pacientes |
Resumen de información revisada por expertos acerca del tratamiento del linfoma de Hodgkin infantil. |
| siguientes procedimientos | 0.539535 |
| células madre | 0.949818 |
| estadio iv | 0.500925 |
| adultos jóvenes | 0.452563 |
| órgano cercano.ampliar linfoma | 0.561365 |
| siguientes elementos | 0.448931 |
| sudores nocturnos | 0.484622 |
| faja ajustadora | 0.430459 |
| siguientes especialistas | 0.43177 |
| siguientes tipos | 0.443725 |
| vÃa oral | 0.419326 |
| rayos x | 0.473568 |
| Hodgkin Lymphoma | 0.582459 |
| abdomen).ampliar linfoma | 0.535694 |
| detecte.ampliar exploración | 0.434601 |
| enlace drugs approved | 0.498183 |
| escáner tep | 0.492453 |
| niño ayuda | 0.424524 |
| estadio iiies | 0.760474 |
| riesgo intermedio | 0.462626 |
| efectos tardÃos | 0.664689 |
| estadio ie | 0.575058 |
| células anormales.ampliar aspiración | 0.485872 |
|
| PDQ Efectos tardÃos | 0.461638 |
| National Cancer Institute | 0.420283 |
| sustancia quizás | 0.427861 |
| siguientes lugares | 0.433237 |
| siguientes riesgos | 0.418851 |
| Instituto Nacional | 0.434896 |
| PDQ Tratamiento | 0.682769 |
| estadio iie | 0.500587 |
| Hodgkin recién | 0.557678 |
| explorador tep | 0.443167 |
| estadio e | 0.45134 |
| nuevos tipos | 0.421275 |
| Physician Data Query | 0.471298 |
| posibles efectos | 0.420063 |
| infancia quizás | 0.428464 |
| estadio iiis | 0.959473 |
| ósea fabrica glóbulos | 0.493208 |
| pelvis.ampliar imágenes | 0.420331 |
| distinta intensidad | 0.419212 |
| almacena células | 0.485736 |
| siguientes pruebas | 0.485604 |
| siguientes estadios | 0.440037 |
|
CLICK HERE |
| 1931 |
National Cancer Institute |
Html |
es |
Tratamiento de los tumores de ovario de bajo potencial maligno (PDQ®)–Versión para pacientes |
Resumen de información revisada por expertos acerca del tratamiento de los tumores de ovario de bajo potencial maligno. |
| potencial maligno recidivantes | 0.922565 |
| siguientes procedimientos | 0.427427 |
| tarde.ampliar ecografÃa abdominal | 0.259992 |
| estadio iv | 0.702134 |
| estadio tardÃo quizás | 0.295045 |
| siguientes aspectos | 0.213133 |
| rayos x | 0.188575 |
| estadio ic | 0.522053 |
| estadio ib | 0.526427 |
| estadio ia | 0.52265 |
| National Cancer Institute | 0.172435 |
| siguientes riesgos | 0.159887 |
| tratamiento quizás | 0.234452 |
| Instituto Nacional | 0.353292 |
| áreas anormales.ampliar examen | 0.232843 |
|
| estadio iiia | 0.49525 |
| PDQ Tratamiento | 0.250127 |
| estadio iiic | 0.497145 |
| estadio iiib | 0.498374 |
| estadio iia | 0.510853 |
| estadio iib | 0.521745 |
| estadio iic | 0.517926 |
| Physician Data Query | 0.359777 |
| potencial maligno causa | 0.737758 |
| maligno causa efectos | 0.613505 |
| siguientes enlaces | 0.168488 |
| ecografÃa transvaginal.Ampliar | 0.196606 |
| histerectomÃa abdominal | 0.202556 |
| siguientes pruebas | 0.233116 |
|
CLICK HERE |
| 1996 |
National Cancer Institute |
Html |
es |
Comunicación en la atención del cáncer (PDQ®)–Versión para pacientes |
Resumen de la información revisada por expertos acerca de la comunicación con el paciente de cáncer y sus familiares, que incluye los aspectos distintivos de la comunicación con pacientes de cáncer, los factores que afectan la comunicación y la capacitación en aptitudes para la comunicación. |
| comunicación mejora | 0.843776 |
| familia ayuda | 0.776248 |
| siguientes casos | 0.791497 |
| Physician Data Query | 0.942554 |
| mejores decisiones | 0.835028 |
| siguientes preguntas | 0.768644 |
| suministra información | 0.764377 |
| salud ayuda | 0.830465 |
| médico ayuda | 0.964949 |
|
| National Cancer Institute | 0.757167 |
| siguientes indicaciones | 0.779865 |
| ¿Cuáles archivos | 0.761738 |
| siguientes riesgos | 0.741613 |
| PDQ Comunicación | 0.825783 |
| comunicación ayuda | 0.895884 |
| Instituto Nacional | 0.809598 |
| ¿Cuáles problemas | 0.755893 |
|
CLICK HERE |
| 2106 |
National Cancer Institute |
Html |
es |
Exámenes de detección del cáncer de endometrio (PDQ®)–Versión para pacientes |
Sumario de información revisada por expertos sobre pruebas que se usan para detectar el cáncer de endometrio. |
| PDQ Tratamiento | 0.669269 |
| general causa sÃntomas | 0.588555 |
| Visuals Online | 0.525614 |
| PDQ Exámenes | 0.596864 |
| cáncer.Los exámenes | 0.641713 |
| Physician Data Query | 0.681868 |
| pequeña cantidad | 0.54391 |
| Estados Unidos | 0.562116 |
| cuello uterino | 0.811632 |
|
| prevención revisa | 0.531482 |
| ecografÃa endovaginal | 0.56717 |
| información ayuda | 0.538498 |
| National Cancer Institute | 0.545187 |
| ecografÃa transvaginal | 0.942856 |
| siguientes riesgos | 0.532576 |
| siguientes sumarios | 0.618993 |
| Instituto Nacional | 0.58569 |
|
CLICK HERE |
| 2114 |
National Cancer Institute |
Html |
es |
Exámenes de detección del cáncer de hígado (hepatocelular) (PDQ®)–Versión para pacientes |
Sumario de información revisada por expertos sobre pruebas que se usan para detectar el cáncer de hígado (hepatocelular). |
| hepatitis c | 0.799278 |
| PDQ Exámenes | 0.723065 |
| estudio marcadores | 0.652784 |
| siguientes efectos | 0.659695 |
| Physician Data Query | 0.826748 |
| Estados Unidos | 0.932003 |
| rayos x | 0.659043 |
| prevención revisa | 0.639071 |
| sustancias dañinas | 0.671115 |
|
| cuerpo usa | 0.666699 |
| ondas sonoras | 0.6623 |
| siguientes exámenes | 0.740755 |
| información ayuda | 0.645281 |
| National Cancer Institute | 0.657644 |
| siguientes riesgos | 0.650336 |
| siguientes sumarios | 0.743208 |
| Instituto Nacional | 0.706872 |
| múltiples funciones | 0.667669 |
|
CLICK HERE |
| 2987 |
National Cancer Institute |
Html |
en |
Secondhand Smoke |
When you smoke, it doesn't just affect you. And it's not just irritating to those around you, it's deadly. |
| feet | 0.409991 |
| dangers | 0.420271 |
| Lung cancer | 0.428942 |
| good example | 0.428021 |
| non-smoker | 0.407426 |
| care staff | 0.426607 |
| nicotine affect | 0.427281 |
| babysitters | 0.406286 |
| body | 0.411562 |
| smoker | 0.414092 |
| children | 0.431937 |
| harms | 0.407652 |
| sure caretakers | 0.428123 |
| secondhand smoke | 0.971613 |
| non-smokers | 0.43912 |
| heart disease‚ | 0.429635 |
| Fact | 0.410452 |
| short time | 0.429909 |
| somebody | 0.406088 |
| health problems | 0.428728 |
| smokefree restaurants | 0.432863 |
| lung infections | 0.428228 |
| smoking indoors | 0.445671 |
| main way smoking | 0.477206 |
| Breathing problems | 0.428866 |
|
| indoor public places | 0.450365 |
| babies | 0.424287 |
| smokers | 0.419121 |
| air | 0.417572 |
| life | 0.412446 |
| Breathing secondhand smoke | 0.5983 |
| infant death syndrome | 0.453829 |
| smoking | 0.508887 |
| National Cancer Institute | 0.448359 |
| heart attack‚ | 0.429618 |
| kids | 0.411336 |
| quiz | 0.411311 |
| cigarette | 0.405834 |
| coughing‚ extra phlegm‚ | 0.454984 |
| bronchitis | 0.405901 |
| people | 0.432125 |
| home | 0.416331 |
| nannies | 0.405803 |
| severe attacks | 0.428972 |
| best thing | 0.428251 |
| shortness | 0.406847 |
| ear infections | 0.428442 |
| low birth weight | 0.454001 |
| family | 0.425482 |
|
CLICK HERE |
| 15641 |
National Cancer Institute |
Html |
en |
Research Performance Progress Report (RPPR) |
Find more information about the RPPR, which documents recipient accomplishments and compliance with terms of award. |
| non-competing renewal | 0.483928 |
| public access policy | 0.676757 |
| NCI program | 0.46997 |
| business official | 0.461707 |
| grants management specialist | 0.511753 |
| Institutional Review Board | 0.501375 |
| recipient accomplishments | 0.470927 |
| progress reports | 0.710572 |
| budget period | 0.703772 |
| Performance Progress Report | 0.705145 |
| competing project period | 0.527715 |
| NCBI | 0.472549 |
| NIH staff | 0.493692 |
| Type 4s | 0.462417 |
| additional information | 0.516454 |
| email notification reminders | 0.504215 |
| award progress reports | 0.597891 |
| PubMed Central ID | 0.510154 |
| budget periods | 0.468611 |
| Progress Report Additional | 0.614182 |
| multiple PIs | 0.466396 |
| contact PI | 0.464615 |
| award process | 0.523874 |
| Management staff review | 0.506533 |
| final peer-reviewed journal | 0.498525 |
|
| grants management staff | 0.612225 |
| additional information online | 0.514579 |
| recipient wishes | 0.463817 |
| different schedule | 0.465588 |
| Institutional Animal Care | 0.498988 |
| annual progress reports | 0.586399 |
| progress report | 0.93768 |
| scientific progress | 0.590143 |
| subsequent budget period | 0.638937 |
| final progress report | 0.600792 |
| NIH applications | 0.499628 |
| eRA Commons | 0.829812 |
| full-text papers | 0.492864 |
| Non-competing continuation | 0.468466 |
| NCI staff | 0.465398 |
| Streamlined Noncompeting Award | 0.520709 |
| NIH funds | 0.496167 |
| NIH Public Access | 0.629563 |
| RPPR | 0.513098 |
| NIH funding | 0.492377 |
| Research Performance Progress | 0.694309 |
| Business Technology Transfer | 0.507309 |
| incomplete applications | 0.461976 |
| Small Business | 0.499434 |
|
CLICK HERE |
| 16826 |
National Cancer Institute |
Html |
en |
Early Onset Malignancies Initiative |
The Early Onset Malignancies Initiative studies the genomic basis of six cancers that develop at an earlier age, occur in higher rates, and are typically more aggressive in certain minority populations. |
| community sites | 0.48513 |
| control group | 0.496806 |
| certain minority populations | 0.77365 |
| exome sequencing | 0.513318 |
| ethnic populations | 0.59564 |
| ethnic groups | 0.477288 |
| multiple platforms | 0.483426 |
| early detection | 0.483135 |
| tumor behavior | 0.507221 |
| cutting-edge genomic characterization | 0.794697 |
| early age | 0.515521 |
| genomic datasets | 0.554094 |
| patient populations | 0.708455 |
| multiple myeloma | 0.479782 |
| critical research | 0.469762 |
| rich genomic data | 0.741156 |
| cancer types | 0.666255 |
| Thorough clinical data | 0.657553 |
| extensive data | 0.513023 |
| clinical measures | 0.479008 |
| molecular targets | 0.47719 |
| TCGA | 0.415616 |
| tumor progression | 0.525349 |
| earlier age | 0.508182 |
|
| higher rates | 0.504515 |
| important insights | 0.491579 |
| molecular drivers | 0.46961 |
| cancer type | 0.492461 |
| NCI Genome Characterization | 0.808398 |
| early disease | 0.497354 |
| clinical updates | 0.489197 |
| disease monitoring | 0.476658 |
| Genome Characterization Pipeline | 0.932301 |
| collaborative initiative | 0.505734 |
| NCI genomic characterization | 0.824673 |
| EOMI | 0.680345 |
| NCI Community Oncology | 0.754977 |
| total RNA sequencing | 0.668278 |
| underrepresented minorities | 0.53639 |
| Cancer Genome Atlas | 0.669216 |
| tissue samples | 0.659999 |
| Early Onset Malignancies | 0.747146 |
| EOMI data | 0.528397 |
| treatment response | 0.492799 |
| cancer risk | 0.496991 |
| genome sequencing | 0.549082 |
| Cancer Prevention | 0.5334 |
| normal tissue samples | 0.654735 |
|
CLICK HERE |